Prostate Cancer Possibly Linked to Zinc Intake

Share this content:
In a Spanish study, the highest vs tertile of dietary zinc intake was associated with a significant 66% increased relative risk of low-grade prostate cancer.
In a Spanish study, the highest vs tertile of dietary zinc intake was associated with a significant 66% increased relative risk of low-grade prostate cancer.

High dietary intake of zinc, a key trace element in normal prostate cell metabolism, may be associated with an elevated risk of low-grade prostate cancer (PCa), a new study suggests.1

In a case-control study conducted in Spain, investigators found that men in the highest tertile of dietary zinc intake (greater than 10.53 mg/day) had a significant 66% increased relative risk of Gleason 6 PCa compared with those in the lowest tertile (less than 8.34 mg/day), in adjusted analyses, Enrique Gutiérrez-González, MD, of the National School of Public Health, Carlos III Institute of Health, Madrid, and colleagues reported in Nutrients.

The study found no significant associations between zinc intake and higher-grade or more advanced PCa tumors.

Continue Reading Below

The investigators also looked at genotype information from selected patients with available DNA (514 cases and 81 controls) and found evidence suggesting that the possible deleterious effect of higher zinc intake on PCa risk is greater among men with a stronger genetic predisposition to PCa.

The investigators cited previous research showing that zinc is involved in the process of proliferation and apoptosis cell regulation in the prostate, and zinc concentrations are consistently lower in PCa tissue than in normal cells. Additionally, zinc depletion in PCa tissue has been related to Gleason score and tumor aggressiveness, Dr Gutiérrez-González and colleagues noted.

The study included 733 incident PCa cases and 1228 population-based controls. Investigators assessed dietary zinc intake using a food frequency questionnaire. Compared with controls, PCa patients had a higher percentage of men with a family history of PCa (21% vs 7%) and lower educational level. PCa patients also had a greater daily alcohol consumption.

Reference

  1. Gutiérrez-González E, Castelló A, Fernández-Navarro P, et al. Dietary zinc and risk of prostate cancer in Spain: MCC-Spain Study. Nutrients. 2018; published online ahead of print. https://www.mdpi.com/2072-6643/11/1/18

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs